Design and Synthesis of 2-Naphthoate Esters as Selective Dopamine D4 Antagonists-Reference-Cited by-同舟云学术

Design and Synthesis of 2-Naphthoate Esters as Selective Dopamine D4 Antagonists

Published:1996-01-01 Issue:10 Volume:39 Page:1946-1948
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Boyfield Izzy¹,Brown Thomas H.¹,Coldwell Martyn C.¹,Cooper David G.¹,Hadley Michael S.¹,Hagan Jim J.¹,Healy Maureen A.¹,Johns Amanda¹,King Ron J.¹,Middlemiss Derek N.¹,Nash David J.¹,Riley Graham J.¹,Scott Emma E.¹,Smith Stephen A.¹,Stemp Geoffrey¹

Affiliation:

1. SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, U.K.

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm960017l

Reference14 articles.

1. Cloning of the cDNA and gene for a human D2 dopamine receptor.

2. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

3. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homology modeling, molecular dynamic simulation, and docking based binding site analysis of human dopamine (D4) receptor;Journal of Molecular Modeling;2015-02

2. Access to Optically Active 3-Azido- and 3-Aminopiperidine Derivatives by Enantioselective Ring Expansion of Prolinols;Organic Letters;2011-07-27

3. Dopamine Receptor Subtype-Selective Drugs: D2-Like Receptors;The Dopamine Receptors;2009-09-19

4. Synthesis of 5-[(4-phenylpiperazin-1-yl)methyl]pyrrolo-[2,3-d]pyrimidine derivatives as potential dopamine D4 receptor ligands;Journal of Heterocyclic Chemistry;2007-03

5. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part I: Influence of the substitution on the basic nitrogen and the position of the amide on the affinity for D2L, D4.2, and 5-HT2A receptors;Bioorganic & Medicinal Chemistry Letters;2007-03